"Isolate Id","Study","Species","Organism Group","Country","State","Gender","Age Group","Speciality","Source","In / Out Patient","Year","Phenotype","MIC","breakpoint","Drug"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"0.5","Susceptible","Amikacin"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,">32","Resistant","Amoxycillin clavulanate"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"16","Intermediate","Ampicillin"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"<=0.12","Susceptible","Cefepime"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"0.12","Susceptible","Ceftazidime"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"<=0.06","Susceptible","Ceftriaxone"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"4","Resistant","Imipenem"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"0.12","Susceptible","Levofloxacin"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"0.12","Susceptible","Meropenem"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"0.5","Susceptible","Piperacillin tazobactam"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"2","Susceptible","Tigecycline"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"<=0.015","Susceptible","Aztreonam"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"0.12","Susceptible","Ceftaroline"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"<=0.015","Susceptible","Ceftazidime avibactam"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"0.25","Susceptible","Doripenem"
"1622649","Inform","Providencia, non-speciated","Enterobacteriaceae","Poland",NA,"Male","19 to 64 Years","Medicine General","INT: Wound","Inpatient","2017",NA,"0.12","Susceptible","Ceftolozane tazobactam"
